{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:07:33Z","timestamp":1748664453487,"version":"3.41.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>Lysyl hydroxylase 2 (LH2), an isoform of hydroxylase, catalyses the hydroxylation of lysine residues in the telopeptide of collagen to form stable and irreversible cross-linkages in collagen. Increased activity of this enzyme in activated stellate cells in human liver has been proposed to relate to the promotion of hepatic fibrosis. In the present study, we examined the regulation of LH2 expression in drug-induced liver injury in order to clarify the mechanisms behind the hepatic fibrosis caused by certain drugs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The mRNA and protein expression of the target gene were detected by real-time reverse transcription-polymerase chain reaction (RT-PCR) with specific primers and Western blotting with a specific antibody, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key findings<\/jats:title><jats:p>The expression of LH2 was increased in HepG2 cells incubated with acetaminophen and isoniazid. This increase was accompanied by an increase in the expression of c-myeloblastosis viral oncogene homolog (Myb) mRNA. Over-expression of c-Myb in cells transfected with a c-Myb expression plasmid, pMbm I, caused an increase in the expression of LH2 mRNA. Mutation of the Myb-binding site in the promoter region of the LH2 gene resulted in a loss of transcriptional activation in the reporter gene assay.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>These results suggest that c-Myb modulates the expression of the LH2 gene in HepG2 cells incubated with drugs causing hepatic fibrosis<\/jats:p><\/jats:sec>","DOI":"10.1211\/jpp.62.04.0010","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T20:54:51Z","timestamp":1441313691000},"page":"477-484","source":"Crossref","is-referenced-by-count":1,"title":["Up-regulation of the lysyl hydroxylase 2 gene by acetaminophen and isoniazid is modulated by transcription factor c-Myb"],"prefix":"10.1093","volume":"62","author":[{"given":"Masafumi","family":"Kubota","sequence":"first","affiliation":[{"name":"Department of Medical Pharmaceutics, Gifu Pharmaceutical University ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Shinoda","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmaceutics, Gifu Pharmaceutical University ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmaceutics, Gifu Pharmaceutical University ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukari","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmaceutics, Gifu Pharmaceutical University ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Usui","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmaceutics, Gifu Pharmaceutical University ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kiho","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmaceutics, Gifu Pharmaceutical University ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmaceutics, Gifu Pharmaceutical University ,","place":["Japan"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,4,1]]},"reference":[{"key":"2024103013102203800_cit1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJM199510263331706","article-title":"Drug-induced hepatotoxicity","volume":"333","author":"Lee","year":"1995","journal-title":"N Engl J Med"},{"key":"2024103013102203800_cit2","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1248\/bpb.28.1148","article-title":"Identification of differentially expressed genes in hepatic HepG2 cells treated with acetaminophen using suppression subtractive hybridization","volume":"28","author":"Iguchi","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"2024103013102203800_cit3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-3565(25)29663-X","article-title":"Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism","volume":"187","author":"Mitchell","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"2024103013102203800_cit4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1067\/mcp.2002.121857","article-title":"The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage","volume":"71","author":"Schiodt","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"2024103013102203800_cit5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-5793(88)81021-4","article-title":"The influence of culture medium composition on drug metabolising enzyme activities of the human liver derived Hep G2 cell line","volume":"241","author":"Doostdar","year":"1988","journal-title":"FEBS Lett"},{"key":"2024103013102203800_cit6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/bj1440115","article-title":"Activities of prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase in the liver of rats with hepatic injury","volume":"144","author":"Risteli","year":"1974","journal-title":"Biochem J"},{"key":"2024103013102203800_cit7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/bj1580361","article-title":"Intracellular enzymes of collagen biosynthesis in rat liver as a function of age and in hepatic injury induced by dimethylnitrosamine. Changes in prolyl hydroxylase, lysyl hydroxylase, collagen galactosyltransferase and collagen glucosyltransferase activities","volume":"158","author":"Risteli","year":"1976","journal-title":"Biochem J"},{"key":"2024103013102203800_cit8","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.75.6.2945","article-title":"Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat","volume":"75","author":"Siegel","year":"1978","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024103013102203800_cit9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.matbio.2004.06.001","article-title":"Increased formation of pyridinoline cross-links due to higher telopeptide lysyl hydroxylase levels is a general fibrotic phenomenon","volume":"23","author":"Van der Slot","year":"2004","journal-title":"Matrix Biol"},{"key":"2024103013102203800_cit10","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1172\/JCI118304","article-title":"Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-Myb expression","volume":"96","author":"Lee","year":"1995","journal-title":"J Clin Invest"},{"key":"2024103013102203800_cit11","doi-asserted-by":"crossref","first-page":"G321","DOI":"10.1152\/ajpgi.2000.278.2.G321","article-title":"c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cells","volume":"278","author":"Buck","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2024103013102203800_cit12","first-page":"884","article-title":"Constitutive expression of a c-Myb cDNA blocks Friend murine erythroleukemia cell differentiation","volume":"8","author":"Clarke","year":"1988","journal-title":"Mol Cell Biol"},{"key":"2024103013102203800_cit13","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1073\/pnas.91.21.10079","article-title":"Constitutive expression of B-Myb can bypass p53-induced Waf1\/Cip1-mediated G1 arrest","volume":"91","author":"Lin","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2024103013102203800_cit14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal Biochem"},{"key":"2024103013102203800_cit15","first-page":"324","article-title":"Temporal and spatial patterns of proto-oncogene expression at early stages of toxic liver injury in the rat","volume":"65","author":"Herbst","year":"1991","journal-title":"Lab Invest"},{"key":"2024103013102203800_cit16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jcp.1041540212","article-title":"Timing of protooncogene expression varies in toxin-induced liver regeneration","volume":"154","author":"Schmiedeberg","year":"1993","journal-title":"J Cell Physiol"},{"key":"2024103013102203800_cit17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/bbrc.2001.4576","article-title":"Expression profiling of acetaminophen liver toxicity in mice using microarray technology","volume":"282","author":"Reilly","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"2024103013102203800_cit18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/toxsci\/65.1.135","article-title":"Genomics and proteomics analysis of acetaminophen toxicity in mouse liver","volume":"65","author":"Ruepp","year":"2002","journal-title":"Toxicol Sci"},{"key":"2024103013102203800_cit19","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJM199306243282508","article-title":"Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies","volume":"328","author":"Friedman","year":"1993","journal-title":"N Engl J Med"},{"key":"2024103013102203800_cit20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.bi.64.070195.002155","article-title":"Collagens: molecular biology, diseases, and potentials for therapy","volume":"64","author":"Prockop","year":"1995","journal-title":"Annu Rev Biochem"},{"key":"2024103013102203800_cit21","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1074\/jbc.272.11.6831","article-title":"Cloning and characterization of a novel human lysyl hydroxylase isoform highly expressed in pancreas and muscle","volume":"272","author":"Valtavaara","year":"1997","journal-title":"J Biol Chem"},{"key":"2024103013102203800_cit22","first-page":"325","article-title":"Collagen hydroxylases and the protein disulfide isomerase subunit of prolyl 4-hydroxylases","volume":"72","author":"Kivirikko","year":"1998","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"2024103013102203800_cit23","doi-asserted-by":"crossref","first-page":"40967","DOI":"10.1074\/jbc.M307380200","article-title":"Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis","volume":"278","author":"Van der Slot","year":"2003","journal-title":"J Biol Chem"},{"key":"2024103013102203800_cit24","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(78)90740-7","article-title":"Chronic hepatic inflammation and fibrosis due to low doses of paracetamol","volume":"1","author":"Bonkowsky","year":"1978","journal-title":"Lancet"},{"key":"2024103013102203800_cit25","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1001\/jama.1986.03370190120036","article-title":"Centrilobular hepatic fibrosis following acetaminophen-induced hepatic necrosis in an alcoholic","volume":"255","author":"O'Dell","year":"1986","journal-title":"JAMA"},{"key":"2024103013102203800_cit26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/335835a0","article-title":"Viral Myb oncogene encodes a sequence-specific DNA-binding activity","volume":"335","author":"Biedenkapp","year":"1988","journal-title":"Nature"},{"key":"2024103013102203800_cit27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1146\/annurev.bi.49.070180.004521","article-title":"Structurally distinct collagen types","volume":"49","author":"Bornstein","year":"1980","journal-title":"Annu Rev Biochem"},{"key":"2024103013102203800_cit28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0945-053X(99)00023-2","article-title":"B-Myb represses trans-activation of the Col5A2 collagen promoter indirectly via inhibition of binding of factors interacting with positive elements within the first exon","volume":"18","author":"Kypreos","year":"1999","journal-title":"Matrix Biol"},{"key":"2024103013102203800_cit29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1074\/jbc.M204392200","article-title":"Characterization of the c-Myb-responsive region and regulation of the human type I collagen alpha 2 chain gene by c-Myb","volume":"278","author":"Luchetti","year":"2003","journal-title":"J Biol Chem"},{"key":"2024103013102203800_cit30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1042\/bj20031110","article-title":"B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts","volume":"378","author":"Cicchillitti","year":"2004","journal-title":"Biochem J"},{"key":"2024103013102203800_cit31","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/j.1530-0277.1996.tb01692.x","article-title":"Serum markers for hepatic fibrosis in alcoholic liver disease: which is the best marker, type III procollagen, type IV collagen, laminin, tissue inhibitor of metalloproteinase, or prolyl hydroxylase?","volume":"20","author":"Tsutsumi","year":"1996","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"2024103013102203800_cit32","first-page":"S63","article-title":"New prolyl 4-hydroxylase inhibitor reduces procollagen gene expression and enzyme-altered lesions in rat liver cirrhosis","volume":"10","author":"Sakaida","year":"1995","journal-title":"J Gastroenterol Hepatol"},{"key":"2024103013102203800_cit33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/hep.510230416","article-title":"The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient L-amino acid-defined diet","volume":"23","author":"Sakaida","year":"1996","journal-title":"Hepatology"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/62\/4\/477\/60233673\/jpp.62.04.0010.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/62\/4\/477\/60233673\/jpp.62.04.0010.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T11:55:15Z","timestamp":1748606115000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/62\/4\/477\/6135762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,1]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2010,4,1]]},"published-print":{"date-parts":[[2010,4,1]]}},"URL":"https:\/\/doi.org\/10.1211\/jpp.62.04.0010","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"type":"print","value":"0022-3573"},{"type":"electronic","value":"2042-7158"}],"subject":[],"published-other":{"date-parts":[[2010,4]]},"published":{"date-parts":[[2010,4,1]]}}}